Real‐world use of cenobamate in adults: Efficacy and predictors of treatment response
Cenobamate is an efficacious drug. Baseline clinical features of seizure type, lower frequency, fewer failed medications, and clobazam use are associated with treatment response and can inform decisions of trialing cenobamate before considering epilepsy surgery.
Authors
- Michael R. Sperling (ORCID: https://orcid.org/0000-0003-0708-6006)
- Lilach Goldstein (ORCID: https://orcid.org/0000-0003-3701-2294)
- Juan Luis Alcalá-Zermeño (ORCID: https://orcid.org/0000-0003-3143-965X)
- Kathryn N. Devlin (ORCID: https://orcid.org/0000-0003-1722-6316)
- Elizabeth W. Fletman (ORCID: https://orcid.org/0000-0002-6482-3060)
- Itai Loushy (ORCID: https://orcid.org/0000-0002-4880-4054)
- Anna Volski
- Louis Porreca
Institutions
- Thomas Jefferson University (US)
- Tel Aviv University (IL)
- Columbia University Irving Medical Center (US)
- Tel Aviv Sourasky Medical Center (IL)
- Drexel University (US)
Publication Details
- Journal
- Epilepsia
- Published
- 2025-02-11
- DOI
- https://doi.org/10.1111/epi.18297
- Citations
- 10
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 14.71